Page last updated: 2024-08-26

fibrinogen and niacin

fibrinogen has been researched along with niacin in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-199010 (66.67)18.7374
1990's2 (13.33)18.2507
2000's3 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avellone, G; Davì, G; Mandalà, V; Novo, S; Strano, A1
Asplund-Carlson, A; Carlson, LA; Egberg, N; Johansson, JO1
Cisar, LA; Kostis, JB; Philipp, CS; Saidi, P1
Blazing, MA; Guyton, JR; Hagar, J; Kashyap, ML; Knopp, RH; McKenney, JM; Nash, DT; Nash, SD1
Applegate, WB; Chesney, CM; Davis, KB; Elam, MB; Garg, R; Herd, JA; Hunninghake, D; Kennedy, JW1
CATTENEO, C; DE SIMONI, G; FANTILI, U1
JAROSCHEWSKI, AJ; SHAWORONKOWA, EK1
IAROSHEVSKII, AIa; ZHAVORONKOVA, EK1
DE WIT, CD; MOERS, AM1
ALKJAERSIG, N; FLETCHER, AP; SHERRY, S1
BIELAWIEC, M; NILSSON, IM1
SHERRY, S1
AMERY, A; DEVREKER, RA; VERMYLEN, C; VERMYLEN, J1
Allman-Farinelli, MA; Dawson, B1

Reviews

1 review(s) available for fibrinogen and niacin

ArticleYear
Diet and aging: bearing on thrombosis and hemostasis.
    Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:1

    Topics: Aging; Alcohols; Bleeding Time; Carbohydrate Metabolism; Diet; Dietary Fats; Factor VII; Fatty Acids; Fatty Acids, Unsaturated; Fibrinogen; Hemostasis; Humans; Isoflavones; Niacin; Nutritional Physiological Phenomena; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk; Thrombophilia; Thrombosis; Thromboxane A2; Tissue Plasminogen Activator

2005

Trials

4 trial(s) available for fibrinogen and niacin

ArticleYear
Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic men.
    Journal of cardiovascular risk, 1997, Volume: 4, Issue:3

    Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Blood Glucose; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Hemostasis; Humans; Hypertriglyceridemia; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin; Plasminogen Activator Inhibitor 1; Regression Analysis; Tissue Plasminogen Activator; Treatment Outcome; von Willebrand Factor

1997
Effect of niacin supplementation on fibrinogen levels in patients with peripheral vascular disease.
    The American journal of cardiology, 1998, Sep-01, Volume: 82, Issue:5

    Topics: Adult; Antioxidants; Arterial Occlusive Diseases; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Fibrinogen; Hemodynamics; Humans; Hypolipidemic Agents; Ischemia; Leg; Male; Middle Aged; Niacin; Warfarin

1998
Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
    Archives of internal medicine, 2000, Apr-24, Volume: 160, Issue:8

    Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Delayed-Action Preparations; Double-Blind Method; Female; Fibrinogen; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Niacin; Triglycerides

2000
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT).
    American heart journal, 2000, Volume: 140, Issue:4

    Topics: Aged; Anticoagulants; Antioxidants; Arterial Occlusive Diseases; Ascorbic Acid; beta Carotene; Blood Coagulation; Disease Progression; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinogen; Humans; Male; Niacin; Vitamin E; von Willebrand Factor; Warfarin

2000

Other Studies

10 other study(ies) available for fibrinogen and niacin

ArticleYear
Effects of sorbinicate and nicotinic acid on blood viscosity, red cell deformation and platelet function.
    Pharmacological research communications, 1982, Volume: 14, Issue:7

    Topics: Adult; Blood Platelets; Blood Viscosity; Cholesterol; Erythrocytes; Female; Fibrinogen; Humans; Male; Malondialdehyde; Middle Aged; Niacin; Nicotinic Acids; Sorbitol; Time Factors; Triglycerides

1982
[Determination of prothrombin time (Quick test) and plasma fibrinogen in pulmonary tuberculosis treated with pyrazinamide].
    Minerva medica, 1957, Feb-07, Volume: 48, Issue:11

    Topics: Fibrinogen; Humans; Niacin; Nicotinic Acids; Prothrombin Time; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary

1957
[PIRAZINAMIDE-ISONIAZID combined therapy for pulmonary tuberculosis; original treatment in cases with unified background factors. I].
    Kekkaku : [Tuberculosis], 1957, Volume: 32, Issue:8

    Topics: Fibrinogen; Isoniazid; Niacin; Nicotinic Acids; Tuberculosis; Tuberculosis, Pulmonary

1957
[COAGULATION AND ANTICOAGULATION FACTORS IN THE BLOOD AND THEIR ALTERATION IN DISORDERS OF CORONARY CIRCULATION].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1963, Aug-01, Volume: 18

    Topics: Angina Pectoris; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Coronary Circulation; Coronary Disease; Fibrinogen; Fibrinolysin; Heparin; Humans; Myocardial Infarction; Niacin; Statistics as Topic

1963
[COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
    Terapevticheskii arkhiv, 1964, Volume: 36

    Topics: Angina Pectoris; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Circulation; Coronary Disease; Drug Therapy; Factor VII; Fibrinogen; Fibrinolysis; Heparin; Myocardial Infarction; Niacin; Prothrombin Time; Toxicology

1964
[EFFECT OF INCREASED FIBRINOLYSIS ON PLASMA FIBRINOGEN; A HYPOTHESIS CONCERNING THE ORIGIN OF AFIBRINOGENEMIA].
    Nederlands tijdschrift voor geneeskunde, 1964, Aug-01, Volume: 108

    Topics: Afibrinogenemia; Deoxyribonuclease I; Fibrinogen; Fibrinolysis; Hemostatics; Iodine Isotopes; Metabolism; Niacin; Nicotinic Acids; Pharmacology; Physiology; Streptodornase and Streptokinase; Streptokinase; Thrombelastography

1964
FIBRINOLYTIC BLEEDING AND ITS MANAGEMENT.
    Annals of the New York Academy of Sciences, 1964, Jul-09, Volume: 115

    Topics: Aminocaproates; Aminocaproic Acid; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Niacin; Nicotinic Acids

1964
FIBRINOLYSIS AND THE PLASMA PROTEIN ELECTROPHORETIC PATTERN.
    Scandinavian journal of clinical and laboratory investigation, 1964, Volume: 16

    Topics: Aminocaproates; Aminocaproic Acid; Blood Protein Electrophoresis; Coagulants; Deoxyribonuclease I; Fibrinogen; Fibrinolysis; Hemostatics; Humans; Niacin; Nicotinic Acids; Pharmacology; Streptodornase and Streptokinase; Streptokinase

1964
CURRENT STATUS OF THROMBOLYTIC THERAPY.
    Geriatrics, 1964, Volume: 19

    Topics: Antibodies; Deoxyribonuclease I; Drug Therapy; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemorrhagic Disorders; Niacin; Physiology; Plasminogen; Pyrogens; Streptodornase and Streptokinase; Streptokinase; Thrombolytic Therapy; Thrombosis; Toxicology

1964
ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
    The American journal of the medical sciences, 1965, Volume: 249

    Topics: Biomedical Research; Coagulants; Deoxyribonuclease I; Fibrinogen; Fibrinolysis; Niacin; Nicotinic Acids; Pharmacology; Plasminogen; Streptodornase and Streptokinase; Streptokinase; Theophylline; Thrombolytic Therapy

1965
chemdatabank.com